Uroxatral is the brand name of a prescription drug used to relieve urinary complications due to benign prostatic hyperplasia. Commonly called BPH or an enlarged prostate, the disorder afflicts men who are middle-aged or older.
History
The pharmaceutical company Sanofi-Aventis, formerly Sanofi-Synthelabo, markets Uroxatral, which the United States Food and Drug Administration approved in June 2003.
Features
The active ingredient in Uroxatral is alfuzosin hydrochloride, a so-called alpha blocker that relaxes blood vessels and smooth muscles, such as those found in the bladder. It's only available by prescription.
Function
Uroxatral is taken in tablet form in doses of 10 milligrams to relax the muscles in the urinary tract, including around the prostate. This decreases pressure on the urethra from the enlarged gland and facilitates urination.
Side Effects
Potential side effects from using Uroxatral include dizziness, fatigue, and headaches. Inform a medical professional immediately if one or more symptoms occur.
Warning
Uroxatral is not appropriate for women, men younger than 18 years old, men with liver problems, or individuals who already use an alpha blocker or certain antifungal drugs like protease inhibitors.
Tags: alpha blocker